Free press releases distribution network?

Agency / Source: Synergy Research Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services - Synergy Research Group (SynRG), a Russia-based CRO with more than 5-years experience in clinical trials in Russia announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI) - Neeman-Medical.com
Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services

 

PRZOOM - /newswire/ - Moscow, Russia, 2007/09/12 - Synergy Research Group (SynRG), a Russia-based CRO with more than 5-years experience in clinical trials in Russia announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI) - Neeman-Medical.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Synergy Research Group (SynRG) announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI), an India-based CRO. This is the second step made by SynRG in formation of the CRO Worldwide Network being able to compete with global CROs in the bids for large international multi-center clinical studies.

“India as well as Russia is one of the world’s recognized emerging clinical trials market today. Since the very beginning of the Global CRO Alliance idea we’ve been looking for experienced and reliable partner in this country, as the US, India and China are the top strategic area of international interest for Synergy Research Group”, said Nikolay Odintsov, General Director and CEO at SynRG. “The negotiation process took 5 months, we’ve discussed numerous topics and finally are proud to announce that the right partner is found, and the Alliance Agreement is signed between SynRG and Neeman”, said Odintsov.

Mr. B. Anantharaman, Managing Director of Neeman Medical International, mentioned that the company will focus on providing end to end solutions to medium and small pharma and biotech companies including monitoring and Data Management services. The company also provides site management, monitoring and data management services to top pharmaceutical companies like GSK, Novartis, MSD, Johnson & Johnson, Sanofi-Aventis and BMS. Through this alliance, both the companies should be able to leverage the advantages of conducting clinical trials in Russia and India, the emerging hubs for clinical research.

Neeman Medical International (NMI) is one of the leading Clinical Research Organization in India headquartered in New Delhi. It's been operational since 2001 with more than 70 active sites in 17 cities and access to more than 600 qualified GCP/ICH trained investigators, 25,000 beds and 6-8 million outpatients annually with a variety of illnesses. All its 60 Clinical research coordinators are medically qualified MDs (physicians) and ICH/GCP trained. NMI is ISO 9001:2000 certified for site management, monitoring and data management and has conducted over 80 clinical trials.

Igor Stefanov, SynRG’s Director for Business Development commented, “Now we're able to share resources, as a matter of fact we've already sent a proposal to one of our prospects where some Data Management services are assumed to be outsourced from Neeman. We’ll be also doing joint marketing and business development – prepare and send proposals, and conduct presentations to the existing clients and prospects, and assist each other with related language and cultural translation issues.”

“New alliance will also deliver several important benefits to sponsors, and is another step in formation of the CRO Worldwide Network providing sponsors with the global reach, and strong local experience at decent price. Our next target is to find a partner in China. We’ve recently taken part in Russian-Chinese Forum on Biotechnological and Pharmaceutical Industries, and have established a number of good promising contacts”, said Stefanov.

Dr. Ajoy Kumar, CEO of Neeman Medical International highlighted the robust operations for site management, monitoring, data management and pharmacy services. With an operations team located present in around 25 cities in India and a data centre located in New Delhi, the delivery to clients in terms of patient enrollment, clean data and reasonable cost is of utmost importance that will be further strengthened by an alliance in Russia with SynRG.

About SynRG

Synergy Research Group (synrg-pharm.com) is a Russian contract research organization, which has been successfully operating throughout Russia and the CIS member-states since 2002. SynRG™ offers a broad range of services for conducting clinical trials for Russian and foreign pharmaceutical and biotechnological companies – from regulatory affairs to pharmaco-economic surveys. The company has its own clinical depot in Moscow, with the total area of 1950 square feet. Today, Synergy Research Group is represented in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg and Almaty. The company’s headquarters are in Moscow.

About Neeman Medical International

Neeman Medical International (neeman-medical.com) is a 100 percent subsidiary of Max India Limited, headquartered in New Delhi, India. It has been operational since 2001 with more than 70 active sites in 25 cities and access to more than 600 qualified GCP/ICH trained investigators, 25,000 beds and 6-8 million outpatients annually with a variety of illnesses. Out of 140 employees, 100 are Clinical Research Coordinators/Clinical Research Associates/Project managers and all of these are medically qualified MDs (physicians).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Synergy Research Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Igor Stefanov - SynRG-Pharm.com 
+7 495 643 1186 office[.]synrg-pharm.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Synergy Research Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Synergy Research Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today